FIELD: medicine.
SUBSTANCE: DNA is delivered to macroorganism in biocompatible and biodegradable microcapsules made of multilayer polymeric poly-"L"-lysine-alginate membranes protecting DNA from nuclease splitting while delivered to organism cells.
EFFECT: higher efficiency of DNA-vaccines.
1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PRODUCING MICROCAPSULES FOR DNA DELIVERY TO MACROORGANISM | 2009 |
|
RU2409384C1 |
| METHOD OF PRODUCING HYBRID MICROCAPSULES BASED ON POLYARGININE AND GLUTATHIONE FOR DRUG DELIVERY | 2022 |
|
RU2819902C1 |
| RESPIRATORY SYNCYTIAL VIRUS ANTIGENIC COMPOSITIONS AND METHODS | 2011 |
|
RU2609661C2 |
| METHOD OF PRODUCING AN OLIGONUCLEOTIDE COMPLEX FOR MAMMALIAN CELL DELIVERY | 2018 |
|
RU2698726C1 |
| PHOTOCHEMICAL INTERNALISATION FOR MOLECULE TRANSPORTATION TO CYTOSOL | 2001 |
|
RU2333246C2 |
| VACCINE AGAINST VIRAL INFECTIONS | 2000 |
|
RU2217162C2 |
| METHOD OF PRODUCING MICROENCAPSULATED NUTRACEUTICALS | 2023 |
|
RU2820656C1 |
| ENTEROSORBENT FOR DIRECTED SORPTION OF CHOLERA EXOTOXIN, DOSAGE FORM OF ENTEROSORBENT FOR DIRECTED SORPTION OF CHOLERA EXOTOXIN | 2015 |
|
RU2611356C2 |
| MICROPARTICLES FOR DELIVERY OF HETEROLOGOUS NUCLEIC ACIDS | 2001 |
|
RU2295954C2 |
| USING NEURO-DERIVATIVE EMBRYIONIC CELLULAR LINES FOR TRANSPLANTATION THERAPY | 1996 |
|
RU2234338C2 |
